Common drug saves lives

Updated: Jul 28

07 July 2021 | See TV News

The following is from a whistle blower medical practitioner who remains anonymous.

Follow us on Telegram https://t.me/seetvnews

Well well well...more cases won in Supreme Court of IV saving lives! But wasn't that just a conspiracy. One dose of Ivermectin* was all it took to get 81-year-old John Swanson off the ventilator. John’s wife Sandra could not believe it. His story is remarkably similar to other cases of patients who were on their way out with advanced C(V but saved when IV was added. Ralph Lorigo is the lawyer who now has won three court orders forcing New York hospitals to administer IV to dying patients. Incredibly, these three hospitals and their lawyers fought against the patients, arguing they did not have the right to receive the drug despite a valid prescription written by their doctors. In essence, the argument was that they did not have the right to try a potentially life-saving medication. In each of the three cases, the New York State Supreme Court Justices sided with the patient, and in each of the three cases, the patients made near-miraculous recoveries after the IV was given. In each case, these patients were in the Intensive Care Unit on ventilators, unable to breathe on their own, and universally, after the drug was given, they rapidly improved and were able to breathe on their own.


Judith Smentkiewicz made national news in January when her family hired Lorigo after the hospital refused a fourth dose of IV. Smentkiewicz's son and daughter called IV a "miracle drug" in court papers. Attorney Lorigo and his associate Jon F. Minear reported, “This lady was on a ventilator, literally on her deathbed, before she was given this drug. As far as we’re concerned, the judge’s order saved this woman’s life.” The family of Glenna "Sue" Dickinson happened to see a newspaper article of Judith's remarkable story, and they decided to try IV as well. Sue Dickinson, 65, contracted CV on January 7, 2021. She suffered progressive worsening and was admitted to Rochester General Hospital on January 12. She continued to worsen and was placed on a ventilator on January 17. The hospital staff advised that her chances of survival were about 40 percent. With nothing to lose, Natalie Kingdollar,


Dickinson’s daughter, reached out to their family doctor, Tom Madejski, who wrote the prescription. The hospital refused to give Sue the IV. The legal team of Lorigo and Minear drafted an affidavit from Dr. Madejski and sought an injunction. State Supreme Court Justice Frank Caruso ordered the hospital to provide the IV. Dickinson, like Swanson, and Smentkiewicz, came off the ventilator and improved as well. The family reported on Facebook that, "She’s making progress each day, and it’s IV and God making this happen.” She has since been released from the hospital.


IV is widely used by physicians, as there are now 51 studies from around the world, with 50 showing clear benefit and one showing neutral. However, the lone study showing a neutral effect was roundly criticized as flawed in an open letter signed by a group of 120 physicians. Experts worldwide have called for the global and systematic use of IV to prevent and treat CV. Physicians have recently written about a profit motive by regulatory agencies and Big Pharma to block cheap, safe, and effective treatments like IV and H*C*Q in favour of experimental and perhaps more dangerous and arguably less effective vaccines and medicines like Remdesivir. With Remdesivir costing $3,100 per dose and not reducing deaths, the choice of IV is a no-brainer say many doctors. IV costs about $2 per dose. It is safer than Tylenol or most vitamins, says Dr. Pierre Kory of the FLCCC Alliance, a group of expert physicians promoting access and information through a nonprofit organisation.


Dr. Kory and Mr. Lorigo have teamed up to help other hospitalized patients gain access to the life-saving drug. Dr. Fred Wagshul, a Yale-educated physician, is a pulmonary specialist and directs the Lung Centre of America. He is also a founding member of the FLCCC Alliance. Dr. Wagshul notes that the typical dose for hospitalized patients is 0.3 mg of IV per kg of body weight for four days which works out to nine 3 mg tablets daily for four days in a typical 200-pound patient.


Dr. George Fareed, former Harvard professor, advocates combination therapy of IV with HCQ in outpatient cases. The big problem is that information promoting IV is often censored or silenced as quickly as it is provided. Facebook, Reddit, Change .org, YouTube, and others have recently taken down posts on IV citing violation of "community standards." Physicians who employ good judgement and scientific studies are considered violators, as well as those who publish factual accounts of IV-based recovery stories. A recent article exposed the link between large pharmaceutical corporations and government regulatory agencies who have financial entanglements and massive conflicts of interest. The disinformation campaign is evident with the publication of articles attempting to cast IV in a false light, referring to it as an “animal dewormer” that might be a “bad idea” for humans to use. In reality, many drugs are common to both humans and animals for treatment, including antibiotics, antifungals, and antiparasitic agents. Ampicillin, a form of penicillin, has been widely used to treat infections in children like whooping cough, salmonella, and meningitis. It has been routinely used to treat adults for bronchitis, pneumonia, and rheumatic heart disease. It is also consistently employed in veterinary applications to treat calves, cattle, dogs, and cats.


You would never see an article attempting to smear Ampicillin as an animal drug and warn people against taking it. However, we see this propaganda daily trying to influence the general public against IV, a life-saving drug that has been prescribed safely and in billions of doses over the past 40 years for parasitic disease. Dr. Satoshi Omura won the 2015 Nobel Prize in Medicine for his discoveries leading to the development of IV. In his praise for IV and its potential to help in the CV plan*demic,


Dr. Omura recently compared IV to Penicillin, “one of